marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
scPharmaceuticals Financial Statements 2011-2024 | SCPH
Annual Financial Statements scPharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
210 M | 200 M | 118 M | 173 M | 112 M | 69.6 M | 37.8 M | - | - | - | - | - | - |
Shares |
38.5 M | 28.4 M | 27.4 M | 27.3 M | 18.6 M | 18.6 M | 2.96 M | - | - | - | - | - | - |
Historical Prices |
5.44 | 7.05 | 4.31 | 6.34 | 6.1 | 3.9 | 12.8 | - | - | - | - | - | - |
Net Income |
-54.8 M | -36.8 M | -28 M | -32.2 M | -33 M | -29.4 M | -23.8 M | -24.4 M | -10.5 M | - | - | - | - |
Revenue |
13.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
3.81 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-55.4 M | -36.2 M | -25.8 M | -29.9 M | -32.9 M | -29.7 M | -23.4 M | -17.9 M | - | - | - | - | - |
Interest Expense |
8.12 M | 3.3 M | 2.58 M | 2.59 M | 1.77 M | 1.43 M | 797 K | 6.51 M | - | - | - | - | - |
EBITDA |
-55.4 M | -36.1 M | -25.8 M | -29.9 M | -32.5 M | -29.3 M | -23 M | -17.9 M | -10.9 M | - | - | - | - |
Operating Expenses |
- | - | 25.8 M | 29.9 M | 32.9 M | 29.7 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
53.4 M | 20.6 M | 9.78 M | 11.8 M | 8.27 M | 13.7 M | 9.1 M | 6.05 M | 2.58 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement scPharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
39 M | 39 M | 36 M | 38.8 M | 38.7 M | 37.8 M | 34.3 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 27.3 M | 27.3 M | 27.3 M | 23.4 M | 20.2 M | 19.4 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 18.5 M | 18.5 M | 18.5 M | 1.08 M | 1.07 M | 1.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-17.1 M | -14.1 M | - | -15.6 M | -14.2 M | -11.2 M | - | -10.2 M | -9.7 M | -7.73 M | - | -6.55 M | -7.06 M | -7.1 M | - | -9.04 M | -8.3 M | -7.09 M | - | -6.21 M | -7.26 M | -8.72 M | - | -5.76 M | -9.85 M | -8.73 M | - | -5.49 M | -6.54 M | -4.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
8.05 M | 6.1 M | - | 3.8 M | 1.64 M | 2.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.3 M | 1.78 M | - | 1.08 M | 354 K | 605 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-14.4 M | -15.9 M | - | -14.8 M | -13.7 M | -11.6 M | - | -10 M | -9.42 M | -7.24 M | - | -5.9 M | -6.46 M | -6.74 M | - | -8.44 M | -7.68 M | -6.65 M | - | -6.29 M | -7.34 M | -8.85 M | - | -5.84 M | -9.9 M | -8.7 M | - | -5.25 M | -6.52 M | -4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.13 M | 2.1 M | - | 2.06 M | 2.01 M | 1.96 M | - | 377 K | 447 K | 518 K | - | 667 K | 651 K | 636 K | - | 655 K | 639 K | 636 K | - | 398 K | 369 K | 354 K | - | 360 K | 359 K | 342 K | - | 329 K | 132 K | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-14.4 M | -15.8 M | - | -14.8 M | -13.7 M | -11.5 M | - | -9.98 M | -9.41 M | -7.23 M | - | -5.9 M | -6.45 M | -6.73 M | - | -8.43 M | -7.67 M | -6.64 M | - | -6.28 M | -7.33 M | -8.84 M | - | -5.83 M | -9.9 M | -8.69 M | - | -5.24 M | -6.52 M | -4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | 10 M | 9.42 M | 7.24 M | - | 5.9 M | 6.46 M | 6.74 M | - | 8.44 M | 7.68 M | 6.65 M | - | 6.29 M | 7.34 M | 8.85 M | - | 5.84 M | 9.9 M | 8.7 M | - | 5.25 M | 6.52 M | 4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
17.5 M | 17.4 M | - | 14.1 M | 12.1 M | 10.9 M | - | 6.28 M | 4.28 M | 2.89 M | - | 2.21 M | 2.65 M | 2.73 M | - | 3.32 M | 2.54 M | 2.5 M | - | 2 M | 1.84 M | 2.32 M | - | 1.94 M | 5.05 M | 4.65 M | - | 1.66 M | 2.37 M | 2.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency